ARCHIVES

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

Funding Opportunities

September 6, 2002

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998